MedEasy raises capital to better serve Bangladesh’s chronic patients

(From left) MedEasy co-founders Golam Moktadir Prince, Arefin Zaman, and Md Nazmul Hossain / Photo credit: MedEasy

In Bangladesh, nearly 70% of healthcare expenditures are paid out of pocket. This problem is especially acute for the country’s 30 million people with chronic illnesses.

Launched in 2020, MedEasy claims to have over 150,000 users using its platform within just two years.

The Bangladesh-based startup offers doctor video consultations and home delivery of medications. It has just raised a seed round of funding to accelerate its goal of streamlining the healthcare journey for all underserved patients in the South Asian country.

Funding details

• Funding amount: $750,000
• Investors: Seedstars International Ventures, Doha Tech Angels (DTA), Startup Bangladesh Limited, Accelerating Asia, nVentures
• Stage: Seed

MedEasy said that its inventory management system and decentralized distribution network have cut delivery times by 4x compared to its competitors.

The startup considers companies such as Arogga and Banglameds (acquired by Chaldal) as having similar models, but MedEasy believes that it focuses more on serving patients with chronic diseases.

As part of its efforts to improve medicine availability and decrease delivery time, the firm will use a significant portion of the investment to boost its supply chain, technology, and data capabilities.

See also: Could Bangladesh be the next Indonesia?

More details